Opus Genetics Inc (NASDAQ:IRD) does about 860.72K shares in volume on a normal day but saw 1698658 shares change hands in the recent trading day. The company now has a market cap of 60.26M USD. Its current market price is $1.01, marking a decrease of -7.34% compared to the previous close of $1.09. The 52 week high reached by this stock is $2.18 whilst the lowest price level in 52 weeks is $0.65.
The consensus objective for the share price is $6.33, suggesting that the stock has a potential upside of 84.04% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 11, 2025 when Craig Hallum initiated the stock to “Buy” and issued a price target of $6.
The current price level is 1.55%, 9.35%, and -8.89% away from its SMA20, SMA50, and SMA200 respectively, with the IRD price moving below the 50-day SMA on current market day. Opus Genetics Inc (IRD) stock is down -0.98% over the week and 5.83% over the past month. Its price is -15.13% year-to-date and -39.88% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.26 and -1.09 for whole year. Expected sales for next quarter are $3.83M, which analysts say will come at $15.4M for the current fiscal year and next year at $26.67M. In addition, estimates put the company’s current quarterly revenue at an average of $3.75M.
To reach the target analysts have set, the stock logically needs to grow 84.04 percent from here.
Outstanding shares total 45.48M with insiders holding 21.20% of the shares and institutional holders owning 24.42% of the company’s common stock. The company has a return on investment of -245.11% and return on equity of -229.30%. The beta has a value of -0.02. Price to book ratio is 9.06 and price to sales ratio is 4.41.
